Navigation Links
Researchers undertake radical new cancer survivorship study

Researchers from the Macmillan Survivorship Research Group (MSRG), at the University of Southampton, have developed the first study of its kind looking at the experiences and needs of people after primary treatment of colorectal cancer.

It is estimated that around two million people are living with, or beyond, cancer in the UK, with this figure rising by 3% each year. On average over 6,000 patients are diagnosed with cancer each year in Hampshire alone.

Whilst increasing cancer survival rates are to be celebrated, the experiences and needs of those who have completed their treatment have been relatively neglected until now.

The University of Southampton, which celebrates its 60th anniversary this year, has a long standing history of cancer research. It has developed the ColoREctal Wellbeing (CREW) study to look at a number of factors influencing recovery which takes into account the disease itself, the level of treatment patients receive, the support available to them and the range of coping skills they have.

Factors influencing recovery studied within the research include the time it takes a patient to return to feeling 'well', the length of time symptoms of treatment last and the range of things people can do to help return to 'normal' more quickly.

Results from this rigorous theory-informed study will, for the first time, inform health care providers and professionals across the country about what helps or hinders rapid and effective recovery and who has the confidence and ability to manage their own problems. It will also help identify areas for the development of interventions to aid the recovery process of those who may be at risk of experiencing problems.

More than 1,000 patients have been recruited to the study, one of whom is Susan Restorick-Banks from Totton in Hampshire.

Susan was diagnosed with a tumour in her colon in early 2011. She has endured Radiotherapy, surgery to remove the tumour and six months of chemotherapy. She says: "It's been really important for me to participate in this study. By speaking out and giving my views, I feel I'm contributing to the wellbeing of future cancer survivors and it's really the only way researchers have of finding out how people like me cope.

"Whilst I've had a very supportive network around me, and have continued to enjoy life throughout my treatment, I know that other people going through cancer treatment can experience things very differently."

Colorectal cancer has been chosen as the focus for the study as it is one of the most treatable cancers in the UK. It affects both men and women equally and can involve all three forms of basic cancer treatment: surgery, chemotherapy and radiotherapy.

The participants, 187 of whom are from Southampton, will be followed over a two-year period establishing the natural history of the recovery of their health and wellbeing and assessing how quickly they recover after colorectal cancer.

Senior Research Fellow at the University of Southampton and chief investigator for the research Dr Deborah Fenlon says: "Up until now the general focus for cancer research has been on cure and prevention for the disease. Macmillan is uniquely concerned with helping to improve the lives of people living with cancer, and for us it is absolutely imperative we understand the experiences of the two million cancer survivors in order to positively inform the professionals who interact and support these survivors, helping them get the best out of life once treatment is over."

Professor Jessica Corner, Dean of Health Sciences at the University of Southampton and Chief Clinician of Macmillan, says, "As a leading health sciences research-based Faculty, and the only research unit funded by Macmillan, we are extremely proud to be undertaking this radical new research. Our ultimate joint-aim is to help improve the lives of people with cancer by informing health care providers and professionals in practice which help care for the two million plus cancer survivors across the UK. Recruiting more than 1000 patients is a real milestone for the study and we are incredibly grateful to Susan and all those participating and involved in the research."

This study forms part of a trio of research projects being undertaken by Health Sciences researchers from the MSRG. Initial research was conducted into how people manage cancer and cancer-related problems followed by creating and testing an online intervention to support self-management.

Ciarn Devane, Chief Executive of Macmillan Cancer Support, says: "We are delighted to congratulate our Macmillan Survivorship Research Group in their recruitment of their 1,000th research participant to the CREW research study. Macmillan is committed to understanding and using evidence, to help the 2 million people living with cancer in the UK. Work with our academic colleagues is helping us to increase our knowledge and will allow us to develop our services in the future.

"The CREW study is important in helping us learn more about bowel cancer patients and their different needs after treatment. The information gained through research will help us support and improve the lives of the increasing numbers of people who are living with and beyond cancer."


Contact: Becky Attwood
University of Southampton

Related medicine news :

1. Researchers make promising discovery in pursuit of effective lymphoma treatments
2. Breast cancer effectively treated with chemical found in celery, parsley by MU researchers
3. New biomarker test predicts arthritis at much earlier stage, MU researchers say
4. Researchers Test Laxative-Free Colon Scan
5. Mayo Clinic researchers discover biomarkers for prostate cancer detection, recurrence
6. Researchers discover how to overcome poor response to radiotherapy caused by low haemoglobin levels
7. Researchers see BPA effects in monkey mammary glands
8. Geisel researchers sift through junk to find colorectal cancer clues
9. Email vacations decrease stress, increase concentration, researchers say
10. Researchers Rejuvenate Blood-Forming Stem Cells in Mice
11. CNIO researchers describe new functions of cohesin relevant for human disease
Post Your Comments:
(Date:11/25/2015)... Indianapolis, IN (PRWEB) , ... November 25, 2015 ... ... clean water accessible for all, Water For Empowerment ™ attracts volunteers together ... on clean water by empowering women as key stakeholders in the process. The ...
(Date:11/25/2015)... Cokato, MN (PRWEB) , ... November 25, 2015 , ... ... Thanksgiving through Christmas Eve on several models of traditional and far-infrared saunas. ... . Nordic Spruce is the most traditional Finnish sauna wood, and Finnleo uses only ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... direct sauna parts and accessories. , Sauna accessories help improve the bather experience ... and personality. From basic styles for the purist looking for simplicity in design ...
(Date:11/25/2015)... ... November 26, 2015 , ... ... (AUC), European Union (EU), ANDI Pan African Centres of Excellence, and public R&D ... Nairobi (UNON) for the opening of the 5th African Network for Drugs and ...
(Date:11/25/2015)... ... , ... For the first time, Vitalalert is donating half of its earnings ... partnership between the two groups began in 2014 with Vitalalert pledging a portion of ... was founded in 1954 and is an international Christian-based health organization whose mission is ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... --> --> ... The potential to save costs, improve treatment quality and ... fully exploited as yet. Here, particular emphasis is placed ... mobile tablet or directly at the patients, bedside. ... ) -->      (Photo: ...
(Date:11/27/2015)... Research and Markets ( ) has announced the ... report to their offering. ... author the present scenario and growth prospects of the ... market size, the report considers revenue generated from the ... copper IUDs. The report forecasts the global intrauterine devices ...
(Date:11/26/2015)... Bajos, November 26, 2015 Un ... de Bremachlorin para el cáncer avanzado.   ... la terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... combina la inmunoterapia con la terapia fotodinámica de Bremachlorin ... Cancer Research . --> Clinical Cancer Research ...
Breaking Medicine Technology: